CGuard Prime Carotid Stent System, 135cm, 9mx30mm Recall
CGuard Prime Carotid Stent System, 135cm, 9mx30mm Model/Catalog Number: CND0930
FDA recall Class II
Ongoing
FDA lists this Class II recall for CGuard Prime Carotid Stent System, 135cm, 9mx30mm. Review the affected identifiers, reported reason and manufacturer instructions below.
Recall at a glance
- Recall number
- Z-2327-2026
- Recall classification
- Class II
- Enforcement status
- Ongoing
- Initiation date
- May 1, 2026
- FDA report date
- Jun 17, 2026
- Quantity in commerce
- 147 units
- Distribution
- See key details
- FDA cause
- Component design/selection
What is being recalled?
CGuard Prime Carotid Stent System, 135cm, 9mx30mm Model/Catalog Number: CND0930
Affected model & UDI checker
Search the exact identifiers published for Z-2327-2026.
The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.
Affected products
| Model / catalog number | Product | Lot scope reported | UDI / GTIN |
|---|---|---|---|
| CND0930 | CGuard Prime Carotid Stent System, 135cm, 9mx30mm | Check source notice | Not specified |
| Not specified | CGuard Prime Carotid Stent System, 135cm, 9mx30mm | Check source notice | 07290120281738 |
FDA code information
UDI: 07290120281738; all lots/serial numbers manufactured between 02/03/2025 and 02/23/2026
Why was this product recalled?
Stent delivery system may encounter complications during deployment which may result in high resistance or inability to deploy the stent.
These are potential consequences described in the source. The recall reason does not establish how many injuries or incidents occurred.
What actions did INSPIREMD Inc take?
On May 1, 2026, InspireMD, Inc. issued a Urgent Medical Device Recall notification to affected consignees. InspireMD asked consignees to take the following actions: 1. Cease further use of all affected CGuard Prime Carotid Stent Systems identified by the model numbers listed in the letter. 2. Quarantine and segregate all affected units currently in your inventory. Place affected product in a clearly labeled quarantine area to prevent inadvertent use. 3. This notice needs to be passed on to all those who need to be aware within your organization or facilities where the affected devices have been transferred. 4. Please retain a copy of this letter, and keep a copy of the Acknowledgement Form. 5. Complete the attached Acknowledgement Form and return it by email to [email protected] within 2 business days. 6. InspireMD will contact each affected customer to facilitate the return and disposition process.
Read the manufacturer action recorded by FDARecall timeline
Recall initiated by firm
FDA notice posted
FDA classification recorded
FDA enforcement report date
Related FDA submissions
No submission number with an exact verified relationship is linked in the retrieved recall notice.
FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.
Source and update history
- FDA recall notice Z-2327-2026
- openFDA enforcement record · Source release Nov 11, 2026 · Retrieved Nov 21, 2026
- openFDA device recall record · Source release Nov 19, 2026 · Retrieved Nov 21, 2026
- FDA enforcement data
First stored snapshot of this source.
- FDA device-recall notice
First stored snapshot of this source.
The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.
Our data sources and methodology